In the last decade it has become clear that homeobox containing genes (HOX genes) not only play a significant role in regulating body formation, but in addition, they are contributing to organization and regulation of hematopoiesis. Modern molecular technologies showed that deregulated expression or disruption of Hox genes can lead to altered characteristics of blood cells or disturbance of blood cell development. In this paper we review the role of HOX proteins in hematopoiesis and leukemogenesis and speculate about their possible target genes and involvement in lymphomagenesis.
Transcription factors
Transcription factors are sequence-specific DNA-binding proteins with a variety of functions: some are thought to help fold the DNA molecule into distinct domains; others assist in the initiation of DNA replication, and many control gene transcription. Binding affinity to DNA sequences, the concentration of transcription factors and the presence of cofactors are important determinants in gene activation. Transcription factors can be classified according to the three-dimensional structure of their DNA-binding domains. More than 80% of all transcription factors are characterized by zinc finger, helixturn-helix, helix-loop-helix, leucine zipper and winged helix motifs (Table 1) . Moreover, the complexity of transcriptional regulation is increased by formation of functional hetero-or homodimers of transcription factors (for instance c-fos and cjun 1 ), or by participation in large protein complexes (for instance c-myc). Transcription of a particular gene is an event regulated by a complex network of transcription factors. The total set of transcription factors present in a cell -induced by extracellular signals -provides a specific genetic imprint that results in a distinct response. Transcription factors have a regulatory role in proliferation and in all kinds of differentiation processes, like embryogenesis, organogenesis, and also hematopoiesis ( Table 1) .
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Hematopoiesis
Specialized blood cells of all lineages originate from the pluripotent stem cell by hematopoiesis. Blood cells have a limited life-span, and new cells are generated continuously throughout life. The ancestral pluripotent stem cell must therefore Table 1 Grouping of gene families, coding for transcription factors, according to their DNA binding motif, 244 ensure its own survival by proliferation before differentiating into all lineages of blood cells. This balance of proliferation and differentiation is highly dynamic, and pluripotent stem cells and progenitor cells are produced in relation to physiological stresses of the organism (such as bleeding, or infection). The intriguing question arises how this process of blood cell development is controlled, and which genes are involved in this complex process.
Hematopoiesis during embryogenesis
The anatomical site of hematopoiesis changes during early life phases (reviewed by Zon 10 and Auerbach
11
). During embryogenesis, early hematopoiesis occurs in the yolk sac, starting in humans at day 15 and continuing for 6 weeks.
Hematopoietic stem cells -derived from the ventral mesoderm -and vascular progenitors migrate to the yolk sac to form blood cell islands. 12 These islands consist of an endodermal layer (supporting growth), a central core of hematopoietic stem cells, and an endothelial layer that surrounds the blood islands. 13 Although progenitors of most blood cells are present, these stem cells predominantly differentiate into erythroid cells and occasionally into monocytes and megakaryocytes. [14] [15] [16] They are primarily important for embryonic hematopoiesis 17 and die during further development of the embryo. In the embryo itself, an additional population of hematopoietic stem cells is present in the dorsal mesentery (also called the aorta gonad mesonephros region, or AGM). This population initiates definitive hematopoiesis (including that of the lymphoid lineage), first in fetal liver and spleen, and subsequently in bone marrow (BM). 17 BM remains the primary hematopoietic organ in adult life. Developmentally controlled changes in location of blood cell development requires coordinate regulatory decisions in cell fate and reorganization of cells.
Transcription factors in hematopoiesis
Hematopoiesis includes many decisions in lineage commitment that depend on coordinate expression of lineage-specific genes. This development program is governed by transcription factors. Blood cell development is particularly complex because it occurs at different body sites, partly determined by developmental stage. Fetal hematopoiesis occurs in the liver, whereas in adults it is initiated in BM. Lymphoid cells reach their final maturation stage in peripheral lymphoid organs, such as lymphnodes, spleen and extranodal lymphoid tissues. The microenvironment of these specific body sites has a profound influence on the differentiation program. 18, 19 Therefore, genes that can specify positional information, such as homeobox (HOX) genes, might be strongly related with the control of hematopoiesis. 20 Expression studies have revealed a number of transcription factor genes that are active in specific cell lineages and differentiation stages during hematopoiesis. Their function was clarified in vitro by transfection studies, and in vivo by knock-out and transgenic mice experiments. Disruption of transcription factor genes often resulted in a block of terminal differentiation of particular hematological cell types, disclosing their role in a particular lineage. Homeobox genes were originally identified as master control genes during embryonic development, but they affect various steps in hematopoiesis as well. [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] These genes, the class I homeobox genes, are the subject of this review. Although knock-out mice have been generated for several genes of the HOX gene family, defects in hematopoiesis of such knock-out mice have only recently been described for the HOXA9 gene.
33 HOXA9 knock-out mice exhibit disturbed differentiation of myeloid and megakaryocytic cells. Early T cell development is severely affected and associated with decreased intracellular expression of CD3 and the TCR ␤-chain, while at the cell surface expression of IL-7R and E cadherin are reduced. 34 Members of the GATA gene family appear crucial for development of various cell types, like GATA-1 for erythroid cells, [35] [36] [37] [38] and GATA-3 for T-cells. 39 By contrast, GATA-2 plays a role in differentiation of all hemopoietic lineages, suggesting that this gene is required for the expansion of the early progenitor cell pool. [40] [41] [42] Lack of the Ikaros gene resulted in the complete lack of lymphoid cells (including early lymphoid progenitors), suggesting that Ikaros affects differentiation of early hematopoietic progenitor cells into the lymphoid lineage. 43, 44 Several other genes specifically involved in the lymphopoiesis have been found, such as Pax5/BSAP, E2A, Oct-2, PU.1, Ets-1 and Tcf-1. [45] [46] [47] [48] [49] [50] [51] [52] [53] Of these transcription factors both Pax5 and Oct-2 genes belong to the HOX class II genes, which contain a homeobox in addition to another characteristic sequence (see below).
Development of the lymphoid lineage
The stem cell first differentiates into a lymphoid and a myeloid progenitor cell. All lymphocytes are derived from a common lymphoid progenitor cell. Differentiation is accompanied by changes in morphology and immunophenotype, eg loss of stem cell marker CD34 during differentiation and induction of lineage-specific markers such as CD19 and CD22. Lymphocytes are responsible for the body's response to foreign antigen. As the number of potential antigens is enormous, this requires a large pool of lymphocytes, each displaying specificity for a single antigen. Antigen responses are divided into the humoral immune response, mediated by B cells, and the cellular immune response, mediated by T cells.
Stimulated by specific cytokines like IL-7 and Flt3 ligand, B cells initially develop in the BM. Their maturation is accompanied by rearrangement of immunoglobulin (Ig) genes encoding their membrane-associated antigen receptor. This produces a large population of B cells each expressing their unique Ig molecules. Immature B cells with a self-reactive receptor are negatively selected before they leave the BM. After migration and homing to lymph nodes, follicular B cells that recognize the appropriate antigen on follicular dendritic cells continue to mature in the germinal center reaction. 54 During this process cells with an antigen-specific Ig receptor are selected to survive, 55 and will further differentiate into plasma cells and memory B cells. Cells without antigen specificity, or expressing a self-specific antigen receptor, undergo programmed cell death (apoptosis).
T cell development occurs primarily in a separate organ, the thymus. This gland is formed from the third pharyngeal pouch and consists of well-defined cortical and medullar zones. Immature prothymocytes enter the thymus, attracted by chemotactic factors. Here, they interact with stromal cells that produce lineage-specific cytokines such as IL-7, stem cell factor (SCF), Flt3 ligand and tumor growth factor (TGF). This drives the T cells into further differentiation. 56 T cells acquire antigen receptor diversity by rearrangement of T cell receptor (TCR) genes, 54 followed by selection for T cells reacting with non-self antigens. 57 This process generates various types of Thelper cells (CD4 positive) and cytotoxic T cells (CD8 positive). 58, 59 Commitment and differentiation of cells to the lymphoid lineage is under precise genetic control, and there is evidence that especially the HOXC cluster plays a role in this regulatory process.
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Development of non-lymphoid lineages
All non-lymphoid blood cells are derived from a common myeloid progenitor cell. Progenitors differentiate along particular lineages to mature blood cells, under influence of a multilineage stimulating factor (IL-3) and lineage-restricted growth factors (eg IL-5, Epo (erythropoietin) and GM-CSFs (granulocyte-macrophage colony-stimulating factors). 60 This is accompanied with downregulation of the progenitor marker CD34 and induction of lineage-specific markers such as CD15 (granulocyte), CD14 and CD68 (monocyte/microphage), CD41 and CD42 (megakaryocyte) and H-antigen, which forms the backbone of the ABO blood group proteins on erythrocytes. 61 Cells also undergo morphological changes, which are most dramatic for erythroid and megakaryocytic development. This results in denucleated erythrocytes and platelets, respectively. 62 Commitment and differentiation of myeloid cells is carefully controlled. Genes of the HOX cluster are involved in this process: HOXA for the myeloid lineage, HOXB for the erythroid lineage. Recent studies suggest that HOXC genes might also be involved in myeloid differentiation.
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Homeobox genes
General aspects of homeobox genes
Homeobox genes are characterized by the presence of a conserved 183 bp sequence, the homeobox ( Figure 1 ) first discovered in genes of the fruit-fly Drosophila melanogaster. 63 Nuclear magnetic resonance and crystallographic studies showed that the three-dimensional structure of the homeobox is a helix-turn-helix motif, consisting of four helices. [64] [65] [66] [67] [68] This motif recognizes DNA sequences having core sequences ranging from TGAT to TAAT 69, 70 to TTAT and TTAC. Regions outside the homeobox in the variable domain provide binding specificity to homeoproteins for specific DNA sequences. As explained below in the process of binding to DNA, homeoproteins appear to display cooperative binding to other regulatory proteins.
Embryonic expression studies and analysis of homeotic mutants revealed that homeobox genes specify cell identity and positioning in the developing embryo. 19, [71] [72] [73] [74] Some mutations in homeobox genes resulted in the duplication of intact morphological structures to anterior or posterior located segments in Drosophila. For example, the Drosophila homeotic mutant called Antennapedia resulted in formation of an additional pair of legs on the head, instead of antennae. [75] [76] [77] [78] The identification of homeobox genes in many other species indicates that homeobox genes provide an evolutionary conserved elementary regulatory mechanism for major differentiation programs.
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Organization of homeobox genes at the chromosomal level
Homeobox genes are categorized in two large groups. The class I homeobox genes are highly homologous (Ͼ80%) to the
Figure 1
Structure of the homeobox protein. Homeobox proteins are composed of several structural units, including a variable region, which determines a protein's specific activity, a small connective hinge region (IYPWM) and a homeodomain of 60 amino acid sequence, encoded by the homeobox, that is similar in all these proteins. The aminoterminal region of the proteins often begin with MSSLYYXN and the carboxyterminal domain tends to be acidic, indicating that it might act as a transcriptional domain. The homeodomain consists of four alpha helices (1-4), one of which (black) recognizes and binds to a specific DNA sequence in the target genes.
first discovered homeobox gene of Drosophila, called Antennapedia. The class II, or diverged homeobox genes, exhibit Ͻ50% homology to the Antennapedia gene. Class II homeobox genes are grouped in several families, based on the presence of additional conserved sequences, such as the paired box in genes of the Pax family and the POU box in the POU domain family (including members as Oct-1, 2, 3 and 4 and Pit-1). 81 In this review we only discuss the homeobox containing class I gene cluster.
Human class I genes are called HOX genes in the new nomenclature. 82, 83 HOX are organized in clusters, and human HOX elements can partly be aligned with those in Drosphila ( Figure 2 ). Drosophila homeobox genes encompass the antennapedia-complex (ANT-C) and bithorax-complex (BX-C), 84 located on one chromosome. The 39 human HOX genes are organized in four clusters (HOXA, -B, -C and -D), located on chromosomes 7, 17, 12 and 2, respectively. 83, [85] [86] [87] Each cluster contains a minimum of nine HOX genes. HOX genes belonging to different clusters but with highly homologous homeodomains, can be positionally aligned on the chromosome. This arranges HOX genes in 13 paralogue groups; for instance, paralogue group one consists of HOXA1, HOXB1 and HOXD1 ( Figure 2 ). The homology between the homeodomains of HOX genes belonging to the same paralogue group is higher than between those of one cluster, suggesting that first a tandem duplication and subsequently a duplication of the complete cluster occurred during evolution. 80, [88] [89] [90] The genomic organization of HOX genes and cis-regulatory sequences suggest that processes involving enhancer sharing form the basis for highly orchestrated expression of HOX genes, necessary for the guidance of sequential steps in the differentiation pathways.
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HOX gene expression
Each of the four clusters covers a distance of approximately 150-200 kb on the chromosome. 81 Each single gene has a polyadenylation site and is thought to have its own promoter. Normally, at the 5Ј end of the homeobox gene, one or more introns are present. HOXC4, HOXC5 and HOXC6 are particular because they are also under control of a master promoter. 94, 95 It is not known whether transcription from the common promoter or the individual promoters is regular for these genes.
Most HOX genes give rise to more than one RNA transcript, generated by the use of alternative splice sites or by differential promoter use, as has been shown for HOXC6 and HOXA9. [96] [97] [98] Alternative splice variants were described that are functionally equivalent. 99 The distinct tissue distribution of alternative transcripts of several HOX genes implies that there are also alternative transcripts that might encode functionally different proteins. However, it is not known whether all alternative transcripts encode functional proteins. 97, 98, 100 Several mechanisms have been identified that regulate expression of HOX genes. The identification of TAAT sequences and retinoic acid response elements in upstream regions allows the binding and activation or repression by homeoproteins [101] [102] [103] [104] [105] [106] (autoregulation) and activation of expression by retinoic acid. [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] Early HOX gene expression in Drosophila is dependent on segmentation genes of the pairrule (activators) and gap (repressor) families. During later stages of development, the maintenance of HOX expression is guided by the polycomb (Pc-G) and trithorax (Trx-G) genes. [117] [118] [119] [120] [121] [122] Pc-G genes repress HOX-gene transcription, while Trx-G genes contribute to strong expression. [123] [124] [125] Following their discovery in Drosophila, Pc-G genes have also been identified in mammals, including humans, where they appear to have a similar role. [125] [126] [127] [128] [129] [130] [131] The mixed lineage-, or myeloid-lymphoid, leukemia gene (MLL) is the only known human Trx-G gene. 132, 133 Human Pc-G genes are differentially transcribed during development of CD34 + into CD34 − BM progenitor cells, 131 but other than that little else is known about their role in hematopoiesis.
HOX gene expression in embryogenesis and organogenesis
The physical order of the genes is also reflected by the temporal sequence of their activation during embryogenesis and organogenesis. [134] [135] [136] The expression order along the anterior-posterior axis of the embryo is colinear with the 3Ј-5Ј organization of HOX genes on the chromosomes (Figure 2) . 3, 4, 76, [137] [138] [139] Moreover, transcripts of a given HOX gene can usually not be detected in the developing embryo until the product of its 3Ј neighbor is present. This so-called temporal colinearity may occur only in cells with high mitotic rates, resulting in a strong linkage between patterning and growth control and an unidirectional pattern process. 140 The expression domains of HOX genes in vertebrates have marked anterior boundaries, but less sharp posterior boundaries, and this results in extensive overlap of expression domains in the posterior regions. This implies that the nature of body structures which grow out from individual segments apparently depends on the specific combination of HOX products. 141 Involvement of HOX genes in the formation of organs is reflected by their expression in kidney, colon, liver, spleen, skin, spinal cord and hematopoietic cells in human adults. [142] [143] [144] In addition, recent studies of human synpolydactyly and congenital malformations demonstrated the involvement of HOX genes mutations in these syndromes. [145] [146] [147] Furthermore, studies with knock-out mice revealed the involvement of HOX11 in the spleen, 148 Pax1 and Hoxa-3 in the developing thymus [149] [150] while Hoxa3, -b3 and -d3 mutant mice show specific disturbance of thymus, parathyroid and thyroid development. 151 Similarly, mice expressing a Hlx homeobox transgene exhibit severe disturbance of both T and B cell development. 152 Thus, HOX genes not only play a role in development of the embryo, but they also contribute to regulation of hematopoiesis. Importantly, this holds true for both fetus and adult. In the following sections, we shall turn our attention to the significance of HOX genes for control of hematopoiesis, and their involvement in oncogenesis. Furthermore HOX genes might be involved in different types of human solid tumors, 142, 143, [153] [154] [155] however, these malignancies are beyond the scope of this review.
Homeobox genes in hematopoiesis
HOX gene expression in hematopoietic cell lines
Analysis of human and mouse hematopoietic cell lines revealed that some HOX genes were only expressed in cell lines of one hematopoietic lineage, while other HOX genes were expressed in cell lines of several lineages. [42] [43] [44] [156] [157] [158] [159] [160] [161] [162] HOX genes that are expressed in cell lines of all lineages are HOXC8, HOXA7 and HOXB7. HOX genes showing a lineagerestricted expression are HOXA10 (myelomonocytic cell lines), 158 and HOXC4 (predominantly expressed in lymphoid cell lines). 45 Furthermore, expression of all HOXB genes was mainly associated with cell lines of the erythroid lineage. 42, 43 Except for HOXB1, which is not expressed in the hematopoietic compartment, and HOXB13, which has been identified only recently, no expression pattern in other hematopoietic cell lines is yet known of HOXB genes. 163 All, but one 164 study reported that genes of the HOXD cluster are not expressed in the hematopoietic compartment. Taken together, no clear coordinate expression of clustered members of HOX genes was found in particular hematopoietic cell lineages, but instead HOX genes appear expressed in a complex pattern of lineage-and non-lineage restriction.
Functional analysis of HOX gene expression in hematopoietic cell lines:
Several groups made use of the capability of some hematopoietic cell lines to differentiate after induction with an appropriate stimulus. Erythroid-myeloid cell lines transfected with a HOXB6 antisense construct, showed an increase of erythroid features. Transfection with a HOXB6 sense construct resulted in the loss of erythroid features, indicating its involvement in erythropoiesis. 165 Also, retroviral gene transfer of HOXB4 in embryonic stem cells enhanced their erythropoietic potential. 166 HOXB7 is temporarily activated in promyelocytic cell line HL60 after induction with Vit D 3 or TPA leading to monocytic differentiation. By contrast, HL60 cells induced to differentiate into the granulocytic lineage lack HOXB7 expression. This was subsequently confirmed by inhibition of colony formation derived from GM-CSF-stimulated bone marrow (BM) in an antisense assay. 167, 168 Finally, Blatt et al 169 reported that overexpression of HOXB8 (Hox2.4) inhibited the myeloid differentiation of IL-6 inducible mouse cells. Thus, modulation of HOX gene expression in hematopoietic cell lines results in differences in lineage commitment and maturation of these cells.
HOX gene expression in normal hematopoietic bone marrow cells
Analysis of unfractionated normal human BM cells using RNase protection assays demonstrated expression of HOXB2, HOXB6 and HOXA10, 43, 158 indicating that HOX expression in cell lines is not solely due to the transformed state. Furthermore, RT-PCR analysis on small purified subpopulations of CD34 + hematopoietic progenitor cells showed that the number of HOX genes expressed was the highest for the HOXA cluster, and decreased for genes of the HOXB and HOXC clusters. No expression of the HOXD cluster genes was found. [170] [171] [172] [173] Not only the number of HOXA genes, but also the expression level of these genes was higher than that of HOXB genes in enriched CD34
+ subpopulations, including the self-renewing stem cell. 172 In addition, it appeared from two studies that HOX genes are colinearly expressed during differentiation of myeloid and erythroid cells. 172, 173 Downregulation of the 3Ј end located genes (eg HOXB3) was observed in more mature fractions, including the committed progenitor cells, while genes located at the 5Ј end (eg HOXA10) seem to be more actively expressed throughout the CD34 + compartment. Their transcription decreases only when cells progress to mature CD34 − stages. 172 Induction of human progenitors into erythroid and granulocytic lineages in vitro revealed a 3Ј to 5Ј end wave of HOXB gene expression colinear with differentiation, 173 similar to the expression order in the embryonic development (Figure 2) .
Expression of HOX regulatory genes, like Pc-G genes, during human hematopoiesis remains relatively unexplored. Lessard and colleagues 131 demonstrated that the expression level of eight out of nine Pc-G genes is much higher in more mature bone marrow cells than in more primitive populations. Some of these genes (like ENX-1, M31, HP1
HS␣ and HP1 HS␥ ) appear in the earliest clonogenic precursors, whereas other Pc-G genes (M32, M33, Mel-18 and Mph1/Rae3) were only detectable at later stages of differentiation. Interestingly, the ninth known human Pc-G gene, Bmi-1, was detected at low frequencies in mature bone marrow cells but was preferentially expressed in primitive long-term culture-initiating cells with high proliferative potential. Progressive upregulation of Pc-G gene expression possibly induces progressive formation of heterochromatin, ultimately resulting in 3Ј→5Ј closure of the HOX clusters.
Functional analysis of HOX gene expression in normal hematopoiesis:
New techniques, including retrovirus-mediated transfection of HOX genes in mouse BM and the generation of knock-out mice, have made it possible to monitor the effect of modulated HOX expression in vivo. Both overexpression and blocking of expression of one individual HOX gene in bone marrow cells has an enormous effect on development of specific cell pools. For example, mouse BM cells, overexpressing HOXB8 as a result of retroviral transfection, had enhanced capacity to form IL-3-dependent cell lines. 174 Furthermore, an increase was noted in self-renewal of early clonogenic cells, concomitant with expansion of progenitor cells and a propensity to evolve into leukemia.
Sauvageau et al 175 recently demonstrated that overexpression of HOXB4 in normal mouse BM results in an increase of the most primitive cell populations, without development into leukemia or other malignancies. Serial transplantations of bone marrow cells, initially transfected with HOXB4, revealed a 50-fold higher number of totipotent hematopoietic stem cells in primary and secondary recipients, compared with mice bearing a control vector expressing neomycin resistance alone. After retroviral gene transfer in embryonic stem cells, HOXB4 was shown to influence the early progenitors with mixed erythroid/myeloid features and not the progenitors of later stages, specific for the erythroid, granulocytic or monocytic lineage. 176 Also, overexpression of the human paralogue HOXC4 in human hematopoietic progenitor cells, resulted in progenitor cell expansion, without changing their capacity to differentiate properly (Corte, personal communication). These results suggest that paralogue members HOXB4 and HOXC4 may have a similar function during the same time span in hematopoiesis.
Another gene investigated in this model is HOXA10, the expression of which is restricted to myeloid cells. Mice overexpressing HOXA10 in their bone marrow cells have increased numbers of stem cells and myeloid progenitor cells. 177 Additionally, the number of megakaryocytic and primitive blast colonies was increased in the recipient animals. By contrast, HOXA10-overexpressing marrow cells did not contribute to the B cell population, suggesting that HOXA10 switch-off is required for B cell differentiation. Moreover, the HOXA10-transfected animals were extremely susceptible to a myeloproliferative disorder that resembled acute myeloblastic leukemia.
An alternative approach to functional analysis of HOX genes is to reduce or knock-out their normal expression. Using homologous recombination in embryonic stem cells, mice with a defect in HOXA9 were created. 178 Mutants were healthy and fertile, but had reduced numbers of peripheral blood granulocytes and lymphocytes. Lymphoid tissues, spleen and thymus were smaller, and the number of myeloid and B cells was reduced. By contrast, no significant effect on pluripotent stem cells seemed to be observed. 52 However, more recent data of the same investigators (ASH 1998) indicate a major stem cell defect in these animals. These results indicated that HOXA9 activates differentiation of stem cells, myeloid progenitors and, in contrast to HOXA10, lymphoid progenitor cells.
An antisense oligodeoxynucleotides (ASOs) approach has been used to diminish HOX gene function in vivo as well. Blocking expression of HOXA5 with ASOs had a dual effect on growth of BM cells. Firstly, myeloid colony forming was inhibited, and secondly, the erythroid progenitor population was expanded. 179 In contrast to HOXA5, an ASO blockade of several HOXB and C genes led to inhibition of erythroid colony formation. 20, 180 Some pitfalls using the antisense ASOs treatment must be considered, however. First, only a 50% reduction of mRNA levels is generally achieved, and an effect of HOX inhibition may not necessarily be observed. Secondly, ASOs could bind non-specifically and affect the function of other genes.
Expression of HOX genes in hematological malignancies
It will not be surprising that genes which are involved in regulation of differentiation and proliferation can contribute to the malignant transformation of cells, because their deregulated expression could lead to defective control of cell growth. HOX genes not only control the differentiation and proliferation of embryonic cells, but their expression in adult organs 142, 143, 181, 182 also suggests a function in the maintenance of the differentiation state of cells. Aberrant expression of these genes might be a result of DNA amplification, translocated genes, mutations or deregulated gene expression.
Leukemias:
HOX gene mutations associated with leukemias are not known, but some leukemias are associated with irregular expression of HOX genes due to translocation or abnormal gene regulation. Translocations have been reported for class I and II homeobox genes. Class I gene HOXA9 was found to be involved in translocation t(7;11)(p15;p15) present in AML FAB M2-M4, linking the complete HOXA9 gene to a gene for nucleoporin NUP98. 183, 184 Diverged, class II homeobox gene HOX11 is juxtaposed to the J␦1 region of the TCR delta gene in the translocation t(10;14)(q24;q11). This translocation has been found in 5-7% of T-ALL. [185] [186] [187] A variant translocation t(7;10)(q35;q24) fuses HOX11 to the TCR␤ gene on chromosome 7. 188 Since the coding region of HOX11 is not affected by the translocation, 189 deregulated HOX11 expression is thought to be a key event in the development of leukemias. The amino-and carboxyl termini of HOX11, however, seem dispensable for transformation. 190 The transforming capacity of HOX11 was demonstrated in vitro by transfection of HOX11 into NIH 3T3 mouse cells. HOX11 can transactivate various mammalian and yeast promoters, 191 suggesting that the oncogenic activity of HOX11 might not be restricted to T cell leukemias. Retroviral transduction of HOX11 in mouse BM cells, enriched for progenitors, yielded cell lines at high frequency consisting of immature cell lines of the myeloid lineage. 192 However, these cells are IL-3-dependent and showed no leukemogenicity, suggesting that HOX11 promotes proliferation and blocks terminal differentiation of hematopoietic cells. 192 For further progression to malignancy secondary events (eg mutations) are required. Recently, the mechanism by which HOX11 interferes in the regulation of the cell cycle was shown by Kawabe et al. 193 By using a two hybrid system they found that HOX11 can interact with the protein phosphatases PP2A and PP1, resulting in disruption of the G2/M cell cycle checkpoint.
The third translocation, t(1;19)(q23;p13.3), produces a chimeric fusion protein that links the amino-terminal transactivating domain of E2A to the carboxy-terminal DNA binding domain of the diverged class II homeobox containing regulatory gene, PBX1. [194] [195] [196] The translocation correlates with 25% of pre-B ALL. 197 Five alternative splice variants of E2A-PBX1 have been identified. Protein products were shown to possess various transforming potentials. 198 Whether PBX1 alone has transforming potential is unknown, but PBX proteins can form DNA-binding complexes with HOX proteins. 199 These complexes are thought to form the basis for autoregulation and HOX-induced cellular transformation. 199, 200 Inordinate HOX gene expression as a result of abnormal regulation has been observed in leukemic cells compared with their normal counterparts. 181, 201 For example, the diverged class II homeobox containing gene HLX (formerly known as HB24) is strongly expressed in activated lymphocytes and hematopoietic progenitor cells. 202, 203 In samples of ALL and AML, however, very high levels of mRNA transcripts were found, in contrast to the normal levels detected in CML material (which represent more mature cells). 204 Transient expression of HLX into a subpopulation of hematopoietic progenitors resulted in impairment of differentiation into mature hematopoietic cells, suggesting that downregulation of HLX is necessary for normal differentiation of hematopoietic progenitors. That this gene also has oncogenic transformation capacity was proven by the fact that HLX-transfected Jurkat cells induced tumor formation when injected into nude mice. 205 Another example of leukemic transformation through deregulated HOX gene expression is presented by HOXA9. Recent studies have shown that co-activation of the Hoxa9 and Meis1 genes is potentially sufficient for transformation and co-transfection of these genes in mouse hematopoietic cells rapidly leads to development of AML. 206, 207 There is scarce evidence that trx-G and Pc-G genes are directly involved in oncogenesis by HOX proteins. The MLL (Hrx) trithorax gene is implicated in mixed lineage (myeloidlymphoid) leukemia. [208] [209] [210] Knocking out the Bmi-1 Pc-G gene in mice specifically affects expression of HOXC5 and HOXC6, 211 while expression of Bmi-1 as a transgene results in a high incidence of lymphomas. 212 This is most likely related to downregulation of the p16/INKA4 gene, an inhibitor of the cell cycle. 213 The expression of HOXC genes and in particular of the HOXC4 gene, 26 seems to be associated with commitment to the lymphoid lineage. We focussed on the expression of HOXC4, HOXC5 and HOXC6 since these three genes have a common promoter, and produce one mRNA molecule that is spliced in separate transcripts. The expression pattern of these 3Ј end cluster-C genes were studied by RT-PCR in normal hematopoiesis and hematopoietic leukemias. Acute B-and Tlymphatic leukemias showed HOXC4 and -C6 expression but lacked HOXC5 expression like normal lymphoid cells. 27 In the myeloid lineage, the expression patterns of HOXC4 and -C6 were largely similar in neoplastic cells of AML. 32 However, HOXC5 gene transcripts were poorly expressed in these neoplastic cells and in normal myeloid cells. Surprisingly, none of the three genes were expressed in CML. Expression of all three genes could generally be detected in immature AMLs (FAB M1-M4 and M6). In mature (normal) myeloid cells the expression of these genes seemed to be downregulated, 32 agreeing with the results of studies reported in the literature. Mature myeloid leukemias localized in tissue simultaneously expressed HOXC4, HOXC5 and HOXC6 genes, in contrast to leukemic myeloid cells in the same stage of maturity. These findings are suggestive for a relationship between HOXC gene expression and the presence of adhesion molecules at the surface of these cells (see below).
In conclusion, if HOX regulatory genes are of central importance in normal hematopoietic development, then disruption of this pathway might be a common feature in human leukemias. 207 
Non-Hodgkin's lymphomas:
To explain our interest in the relationship between HOXC genes and non-Hodgkin's lymphomas (NHL), we would like to briefly discuss the development of the present conceptual definition of NHL.
NHL form a heterogeneous group of malignant lymphoproliferations. They can be roughly divided into B and T cell lymphomas depending on lineage markers, like Ig-or TCR-gene rearrangements, and markers expressed on the cell surface. In the past, several classifications have been used to describe these various types of lymphomas. The updated Kiel classification is nowadays widely used in Europe. The concept of this classification was that various types of non-Hodgkin's lymphomas are thought to represent malignant counterparts of lymphoid cells. They are arrested at various stages of normal differentiation, while maintaining their proliferating activity. 214 The Kiel classification was mainly based on nodal lymphomas. Extranodal lymphomas, such as mycosis fungoides and maltomas that display unique clinicopathological features, did not fit in this concept. Present insights in the biology of lymphocytes, in particular the recirculation of lymphocytes through the body and homing of lymphocytes to specific body sites, increased our understanding of extranodal lymphomas. 215, 216 The recirculation pattern of lymphocytes is specific for particular body compartments, meaning that there are subpopulations of lymphocytes that home specifically to lymph nodes, to the MALT (mucosa-associated lymphoid tissue) or other body compartments. This homing is mediated by specific adhesion molecules, which react with site-specific adhesion molecules on the endothelial cells of high endothelial venules (HEV), named vascular adressins or tissue position markers. For example, lymphocytes expressing cutaneous lymphocyte antigen CLA (the proposed skin homing receptor 217, 218 ), interact with E-selectin on the superficial dermal vessels. 219 Those expressing the ␣4␤7 integrin, serving as the homing receptor for mucosal sites, interacts with MAd-CAM-1, present on the HEV of the Peyer's patch. 220, 221 This compartmentalization of the immune system is accompanied with different functions and the existence of distinct effector immune cell populations.
Extending the concept of the 'neoplastic equivalent' with this aspect of tissue-restricted lymphocytes, we can now define NHL as neoplastic counterparts of functional recirculating tissue restricted lymphocytes activated after antigen stimulation. 222 From this point of view it is conceivable that lymphomas may arise with similar histologic features, but with different clinical behavior, different translocations, different adhesion molecule expression pattern, or differences in the presence of viral sequences (such as EBV or HTLV-1). Thus, anaplastic lymphomas arising in the skin express CLA, lack the t(2;5) translocation and have a good prognosis. By contrast, nodal anaplastic lymphomas do not express CLA, contain the t(2;5) translocation and normally have an intermediate prognosis.
Given the involvement of HOX genes in hematopoiesis, organogenesis of hematopoietic organs, and pathogenesis of tumors and leukemias, investigation of HOX gene expression in lymphomas seemed warranted.
We studied the expression pattern of the 3Ј end cluster-C genes HOXC4, HOXC5 and HOXC6 in lymphoid hematopoiesis to see whether the expression pattern of HOXC genes in NHL, the neoplastic equivalents of normal lymphoid cells, is altered compared to normal lymphoid cells. Lymphoid B and T cell lines, arrested at different stages of maturity, early ALL, and healthy lymphoid cells from peripheral blood and hyperplastic tonsillar tissue were used as a model for normal lymphoid development. Semiquantitative RT-PCR demonstrated increased expression of HOXC4 and HOXC6 with progressive maturation of both B-and T-lymphocytes. In contrast to HOXC4 and HOXC6 gene expression in neoplastic and normal lymphoid cells, we detected expression of HOXC5 only in lymphoma-derived cell lines and some B cell lymphomas. 27 These findings suggested a role for HOXC5 in lymphomagenesis.
To distinguish HOXC gene expression in normal cells from that in lymphoma cells, we used non-radioactive RNA in situ hybridization (RISH) to determine HOXC transcription at the single cell level. We further analyzed expression of HOXC4, HOXC5 and HOXC6 in histologic subtypes of primary cutaneous lymphomas, in benign cutaneous lymphoid lesions and hyperplastic lymphoid organs. HOXC4 and HOXC6 were detected by RT-PCR and RISH in almost all samples of primary cutaneous NHL, benign lymphoid lesions and hyperplastic lymphoid organs. 223 However, expression of HOXC5 was only detectable by RISH in primary cutaneous anaplastic large T cell lymphomas. Semiquantitative RT-PCR revealed expression of HOXC5 in some other subtypes of cutaneous Band T-NHL, but this was much weaker than in primary cutaneous anaplastic large T cell lymphomas. Since we could not induce HOXC5 expression in PBL stimulated with ␣-CD3/CD28 mAbs in the presence of IL-2, HOXC5 might act as a putative oncogen in the genesis of cutaneous anaplastic large T cell lymphomas. 223 Keeping in mind that HOX genes provide cells with positional as well as developmental information, different histologic subtypes of B-and T-NHL were analyzed for expression of HOXC4, HOXC5 and HOXC6. Expression of HOXC4 and HOXC6 could be detected by RISH in the majority of lymphomas. Interestingly, HOXC6 could not be detected in lymphnode-based B-CLL. HOXC5 gene expression appeared associated with primary cutaneous anaplastic large T cell lymphomas and B cell lymphomas with plasmocytic differentiation from the oro-digestive tract. 30 Thus, HOXC5 showed a type-and site-restricted expression pattern in NHL and may be involved in formation of these lymphomas.
Target genes of homeoproteins
Although expression patterns of many class I HOX genes have been described in embryogenesis and hematopoiesis, the targets of the majority of their protein products have yet to be identified. Genes that have been shown to be controlled by homeoproteins encode adhesion molecules, transcription factors (in particular the HOX genes themselves) and growth factors.
Modulation of adhesion molecule expression
By modulation of HOX gene expression in vitro it was observed that homeoproteins are able to influence the adhesive capacity of myeloid leukemia cells. 224 Adhesion molecules are categorized in the following families: the immunoglobulin (Ig) gene superfamily, cadherins, integrins, selectins and the CD44 family. Analysis of adhesion molecule profile of cells, overexpressing HOX genes, revealed that members from different adhesion molecule families were affected. Examples are given in Table 2 .
Cotransfection experiments demonstrated that the expression of N-CAM, a member of the Ig gene superfamily, is involved in the development of the neural network in embryogenesis. This protein, present on natural killer (NK) cells, could be activated by increased levels of Xenopus HoxC6 and HoxB9. 225, 226 In contrast, HoxB8 had an inhibitory effect on the expression of N-CAM, indicating that tandemly arranged genes, such as HOXB8 and HOXB9, act together to control one gene by differential regulation. 225 In addition, a study of HOX gene expression by the human metastatic melanoma cell line Me 655/2 demonstrated that melanoma clones could be classified into two populations: one group expressed HOX-C genes, which correlated with low level expression of ICAM and absent expression of VLA-2, -5 and -6. By contrast, high level expression of VLA-2, -5 and -6, and ICAM coincided with silence of the HOX-C locus. 227 In addition to these class I genes, class II homeobox genes (Phox2 and Cux) also showed cross-talk by either activating (Phox2) or inactivating (Cux) N-CAM expression. 228 Furthermore, decreased expression of ICAM-1 (CD54) was found in myeloid FDC-P1 cells after enforced expression of the mouse homeobox genes Hlx. 229 In the same study, the expression of CD44 also decreased as a result of the Hlx overexpression.
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CD44 is an integral membrane protein, which is widely distributed over hematopoietic and non-hematopoietic cells. In addition to important adhesion events necessary for migration, T cell activation 230 and probably lymphopoiesis 231, 232 within the bone marrow, a variant of CD44 was shown to have metastatic potential. 233 Integrins can also be modulated by HOX genes. For instance, increased expression of ␣IIb␤3, a surface fibronectin receptor, was induced by HOXD3 in the erythroleukemia cell lines HEL and K562. 164 No example of HOX-mediated regulation of selectins are known. All adhesion molecules have important functions in embryogenesis, morphogenesis, lineage commitment, hematopoiesis and cell migration, stressing the importance of homeoproteins in these cellular events. 
Modulation of transcription factor expression
Another group of target genes of the homeoproteins are genes coding for transcription factors (Table 3 ). The most obvious transcription factors under regulation of homeoproteins are the homeobox genes themselves. Moreover, coordinate expression of HOX genes in embryogenesis is achieved in part by cross-talk between the various members of the HOX complexes. 7, 72, 134 For several HOX genes auto-and/or crossregulatory interactions within the homeotic network have been described by genetic analysis and in transfection assays. [234] [235] [236] [237] For example, human HOXD9 (formerly HOX4C) is transactivated by the HOXD9 protein itself and by HOXD10 (formerly HOX4D) protein by cotransfection. Conversely, mouse Hoxd-8 (formerly Hox-4.3) represses activation of HOXD9. 106 Furthermore, HOXC5 can be transactivated by HOX genes from the same cluster (HOXC6), as well as from the HOXD cluster (HOXD9 and HOXD10) . 102 In vivo experiments with Drosophila and mice indicated that a cofactor is necessary for autoregulation of Hoxb-1. 101 These experiments demonstrate that the HOX cross-talk region (HCR) can be occupied simultaneously by several protein molecules and allows various combinations of HOX proteins to interact. Although no data are present on cross-or auto-regulatory events in hematopoietic cells, these regulatory circuits may be active in hematopoiesis as well.
In addition to regulation of homeobox gene expression by homeoproteins, gene expression of other transcription factors, involved in organogenesis and proliferation, have also been shown to be under control of homeoproteins (Table 3) . Concerning hematopoiesis, it is of interest that knock-out mice for HOXA3 have a reduced expression of the Pax1 gene, suggesting that Pax1 is a target of HOXA3. Moreover, these mutants were athymic, which is in agreement with the phenotype of Pax1 mutant mice. 150 Since Pax1 mutants also had reduced numbers of CD4 +
/CD8
+ immature and CD4 + mature thymocytes, Pax1 is also involved in the maturation of thymocytes. 149 Moreover, the gene encoding transcription factor Thy-1, involved in the maturation of thymocytes, was disclosed as a target of Pax1. The expression order from HOXA3, Pax1 to Thy-1 in the development of the thymus and thymocytes indicates an early function as master control genes for HOX genes in organogenesis and lymphopoiesis.
Modulation of expression of other targets of homeoproteins
Other targets of homeoproteins, not belonging to adhesion molecules or transcription factors are mentioned in Table 4 . Interestingly, the Pax5 protein (BSAP, B-cell lineage-specific activator protein), is able to induce the expression of B cell membrane protein CD19. 34 BSAP is essential for B cell development 34 and deregulated BSAP expression has been implicated in formation of large-cell lymphomas and some follicular lymphomas. 39 The finding that many target genes of homeoproteins are involved in hematopoiesis emphasizes their regulatory role in this process. Furthermore, deregulated HOX gene expression might have profound effects on proliferation and differentiation of a cell, and promote neoplasia.
Epilogue
In this part we will discuss two major aspects which have not been dealt with in the previous sections: general aspects of HOX gene expression in hematopoiesis, and the significance of HOXC5 in NHL.
General aspects of HOX gene expression in hematopoiesis
Our study on HOXC4, HOXC5 and HOXC6 gene expression in myeloid and lymphoid hematopoietic compartments revealed a lineage-and stage-restricted expression pattern of these genes. Other groups showed commitment of some HOX genes to particular lineages or stages of hematopoiesis. An interesting question is whether there are parallels between the function of HOX genes in the formation of the embryonic body plan and their regulatory role in hematopoiesis. In other words, does the homeotic network regulate the process of blood cell maturation by providing positional and temporal information? Secondly, are HOX genes expressed in a spatial and temporal manner during hematopoiesis?
Stage-and lineage-restricted expression patterns of HOX genes in hematopoiesis indicates that their transcription is coordinated in time. Indeed, HOX gene expression during hematopoiesis appears to occur in a pattern similar to that in embryogenesis, starting with the 3Ј genes and progressing to 5Ј genes of the HOX cluster. This 'wave' of HOX gene expression has been found in CD34
+ BM cells 173 and T cells 238 after activation, suggesting a temporal axis of HOX gene expression in hematopoiesis. Moreover, most mature CD34 + subpopulations showed a preference for expression of 5Ј end genes compared to expression of more 3Ј end genes in more immature fractions. 172 Concerning positional information, we have considered a role of homeobox genes in homing of lymphocytes to specific body sites by regulation of adhesion molecules, which would give these cells a positional imprint. Immature blood cells lay ordered in the three-dimensional structure of the BM, interacting with a stromal meshwork through adhesion molecules and cytokines. 19 Progression of maturation is accompanied with migration within the BM, requiring downregulation of adhesion molecules determined by the given BM localization, in combination with expression of other adhesion molecules. Thus, blood cell differentiation is tightly associated with a specific position and a spatial axis, that might be coordinated by HOX genes.
However, the release of hematopoietic cells from BM to peripheral blood requires downregulation or shedding of adhesion molecules. Since it seems possible that adhesion molecule expression can be controlled by homeoproteins, downregulation of the expression of (particular) HOX genes in mature BM populations is also necessary. Compared to CD34 + immature BM cells HOXA10 is only found in CD34 − mature cells. Indeed, transition from the CD34 + to the CD34 − compartment was accompanied with the downregulation of HOXA10 gene expression. 201 This indicates that HOXA10 is temporarily expressed during maturation of immature CD34 + BM cells to mature CD34 + BM cells. When mature BM cells are released in the peripheral blood stream, adhesion molecules are required for the homing of lymphocytes to lymphoid organs and extranodal lymphoid tissues. Therefore, we suggest that a second 'wave' of HOX gene expression is activated, reinducing (other) adhesion mol-ecules. This view is supported by our observation of HOXC4 and HOXC6 expression in mature lymphocytes.
Significance of HOXC5 expression in non-Hodgkin's lymphomas
The regulatory function of HOX genes in cell differentiation and proliferation, made them possible candidates for a role in development of tumors and leukemias. We have proposed a role for HOXC genes in lymphomagenesis. HOXC5 expression was specifically found in anaplastic large T cell lymphomas (predominantly localized in the skin) and in B cell lymphomas with plasmacytic differentiation (mainly originating from the oro-digestive tract). These specific expression patterns of HOXC5 indicate a relationship with (1) lymphomas equivalent to terminal differentiation stages of both B and T lymphocytes; and (2) with development of lymphomas at specific body sites, ie the skin and the oro-digestive tract.
In this respect the link between homeoproteins and activation of adhesion molecule expression 225, 226, 239 is extremely interesting. In both primary cutaneous and primary orodigestive tract lymphomas, site-specific adhesion molecules are expressed, such as the skin-homing receptor CLA and ␣4␤7, the mucosa-associated homing receptor. 240, 241 It is possible that HOXC5 is directly or indirectly involved in expression of these site-specific adhesion molecules. A relationship between HOX gene expression and integrin molecules is supported by the finding that genes coding for integrin chains are clustered in regions of the chromosomes that also contain HOX genes. This suggests co-evolution of these two gene families. 242 Moreover, the position of the ␤7 chain gene near the HOXC cluster on chromosome 12q13, 242 supports the hypothesis that homeoprotein C5 might be involved in modulation of ␣4␤7 expression. To test this hypothesis, transfection experiments should be carried out using HOXC5 constructs, and additionally ␣4␤7 and CLA expression analysis of the transfected cells should be performed. We transfected a vector containing a HOXC5 construct driven by a CMV promoter in pre-B cells. Unfortunately, it was not possible to select for cells containing the construct because transfectants died. Moreover, limiting dilution assays produced cell populations without the HOXC5 construct, indicating that these cells died as a result of high expression of HOXC5 protein due to the strong CMV promoter. Therefore, HOXC5-containing vectors should be constructed containing a weaker or inducible promoter.
Another interesting finding is that HOXC5 is mainly expressed in B and T cell lymphomas equivalent to mature lymphoid differentiation stages. Since HOXC5 could not be found in normal and activated lymphoid cells or benign lymphoid skin lesions, it is not likely that HOXC5 expression in these lymphomas is induced by local micro-environmental factors. Therefore, we suggest that HOXC5 acts as an oncogene in these lymphomas. In addition, HOXC5 activationresulting in expression of site-specific adhesion moleculesmight keep cutaneous anaplastic T cell lymphomas and maltomas of the oro-digestive tract predominantly localized in particular body compartments (skin and oro-digestive tract). This could favourably affect their prognosis.
